Heart failure drug showdown: Once-a-Day pill tested against Twice-a-Day standard

NCT ID NCT03509545

Terminated Disease control Sponsor: Sarfez Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a once-daily dose of Torsemide (a water pill) works as well as the standard twice-daily Furosemide in heart failure patients. The goal was to see how much sodium the body gets rid of and if body weight changes. The study was stopped early and included 20 adults on a stable dose of Furosemide.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BODY WEIGHT CHANGES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Body Weight Changes congestive heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BODY WEIGHT CHANGES

Contacts and locations

Locations

Syngene International

Bangalore, Karnataka, 560099, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.